Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Cervical Cancer

  Free Subscription


18.05.2020

1 Anesthesiology
1 BMC Public Health
1 Cancer Cell Int
1 Cell Biochem Funct
1 Cell Death Dis
1 Chin J Cancer Res
1 Clin Lab
1 Cytokine
1 FEBS Open Bio
1 Front Oncol
1 Genes Genomics
1 Glob Health Promot
1 IEEE Trans Med Imaging
1 Int J Biol Markers
1 Int J Radiat Biol
2 J Cell Physiol
4 J Contemp Brachytherapy
2 J Immunol Res
1 J Infect
1 LGBT Health
1 Mater Sociomed
1 Med Ultrason
1 Minerva Ginecol
1 Mol Biol Rep
1 Mol Cell Biochem
1 Mol Oncol
1 Mol Ther Nucleic Acids
1 Oncol Lett
1 Oncologist
1 Pathol Res Pract
1 PLoS One
1 Prev Med
1 Radiother Oncol
1 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
1 Zhong Nan Da Xue Xue Bao Yi Xue Ban
1 Zhongguo Yi Xue Ke Xue Yuan Xue Bao
1 Zhonghua Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Anesthesiology

  1. ZHANG W, Sheng B, Chen S, Zhao H, et al
    Sevoflurane Enhances Proliferation, Metastatic Potential of Cervical Cancer Cells via the Histone Deacetylase 6 Modulation In Vitro.
    Anesthesiology. 2020;132:1469-1481.
    PubMed         Abstract available


    BMC Public Health

  2. KIND AB, Pavelyev A, Kothari S, El Mouaddin N, et al
    Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.
    BMC Public Health. 2020;20:671.
    PubMed         Abstract available


    Cancer Cell Int

  3. ZHU Y, Zhang X, Wang L, Zhu X, et al
    FENDRR suppresses cervical cancer proliferation and invasion by targeting miR-15a/b-5p and regulating TUBA1A expression.
    Cancer Cell Int. 2020;20:152.
    PubMed         Abstract available


    Cell Biochem Funct

  4. ZHANG X, Liu S, Zhu Y
    A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKbeta pathway in cervical cancer.
    Cell Biochem Funct. 2020 May 13. doi: 10.1002/cbf.3547.
    PubMed         Abstract available


    Cell Death Dis

  5. ZHANG K, Liu L, Wang M, Yang M, et al
    A novel function of IMPA2, plays a tumor-promoting role in cervical cancer.
    Cell Death Dis. 2020;11:371.
    PubMed         Abstract available


    Chin J Cancer Res

  6. HAN Q, Guo H, Geng L, Wang Y, et al
    p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening.
    Chin J Cancer Res. 2020;32:208-217.
    PubMed         Abstract available


    Clin Lab

  7. LIANG H, Guo X, Li Y
    Cervical Cancer Associated Biomarkers of Identify High Risk of Venous Thrombosis.
    Clin Lab. 2020;66.
    PubMed         Abstract available


    Cytokine

  8. TORRES-PINEDA DB, de Lourdes Mora-Garcia M, Garcia-Rocha R, Hernandez-Montes J, et al
    Corrigendum to "Adenosine augments the production of IL-10 in cervical cancer cells through interaction with the A2B adenosine receptor, resulting in protection against the activity of cytotoxic T cells" [Cytokine 130 (2020) 155082].
    Cytokine. 2020 May 8:155110. doi: 10.1016/j.cyto.2020.155110.
    PubMed        


    FEBS Open Bio

  9. LIN SL, Wang M, Cao QQ, Li Q, et al
    Chromatin modified protein 4C (CHMP4C) facilitates the malignant development of cervical cancer cells.
    FEBS Open Bio. 2020 May 14. doi: 10.1002/2211-5463.12880.
    PubMed         Abstract available


    Front Oncol

  10. CHAMBUSO RS, Rebello G, Kaambo E
    Personalized Human Papillomavirus Vaccination for Persistence of Immunity for Cervical Cancer Prevention: A Critical Review With Experts' Opinions.
    Front Oncol. 2020;10:548.
    PubMed         Abstract available


    Genes Genomics

  11. LAI Y, He Z, Zhang A, Yan Z, et al
    Tip60 and p300 function antagonistically in the epigenetic regulation of HPV18 E6/E7 genes in cervical cancer HeLa cells.
    Genes Genomics. 2020 May 12. pii: 10.1007/s13258-020-00938.
    PubMed         Abstract available


    Glob Health Promot

  12. ADSUL P, Nayaka S, Pramathesh R, Gowda S, et al
    Using photovoice to understand the context of cervical cancer screening for underserved communities in rural India.
    Glob Health Promot. 2020 May 13:1757975920915677. doi: 10.1177/1757975920915677.
    PubMed         Abstract available


    IEEE Trans Med Imaging

  13. LI Y, Chen J, Xue P, Tang C, et al
    Computer-aided Cervical Cancer Diagnosis using Time-lapsed Colposcopic Images.
    IEEE Trans Med Imaging. 2020 May 14. doi: 10.1109/TMI.2020.2994778.
    PubMed         Abstract available


    Int J Biol Markers

  14. HUANG L, Mo Z, Zhang L, Qin S, et al
    Diagnostic Value of Albumin to Fibrinogen Ratio in Cervical Cancer.
    Int J Biol Markers. 2020 May 11:1724600820915916. doi: 10.1177/1724600820915916.
    PubMed         Abstract available


    Int J Radiat Biol

  15. ZENG X, Wan L, Wang Y, Xue J, et al
    Effect of Low Dose of Berberine on the Radioresistance of Cervical Cancer Cells via a PI3K/HIF-1 Pathway under Nutrient Deprived Conditions.
    Int J Radiat Biol. 2020 May 15:1-16. doi: 10.1080/09553002.2020.1770358.
    PubMed         Abstract available


    J Cell Physiol

  16. ZHAO J, Li L, Yang T
    MiR-216a-3p suppresses the proliferation and invasion of cervical cancer through downregulation of ACTL6A-mediated YAP signaling.
    J Cell Physiol. 2020 May 13. doi: 10.1002/jcp.29783.
    PubMed         Abstract available

  17. GOLSHEKAN E, Sohrabi A
    The point mutation analysis of Cyp2C9(*2) (Arg144Cys C>T), Cyp2C9(*3) (Ile359Leu A>C) and VKORC1 (1639G>A) in women with cervical cancer related to HPV: A case-control study.
    J Cell Physiol. 2020 May 12. doi: 10.1002/jcp.29731.
    PubMed         Abstract available


    J Contemp Brachytherapy

  18. CARRASCO N, Chimeno J, Adria-Mora M, Perez-Calatayud MJ, et al
    Inter-observer and intra-observer variability in reporting vaginal dose points for cervical cancer in high-dose-rate brachytherapy.
    J Contemp Brachytherapy. 2020;12:139-146.
    PubMed         Abstract available

  19. SHAHBAZIAN H, Birgani MJT, Bagheri A, Arvandi S, et al
    Evaluation of rectal volume correlation with dosimetric parameters during optimized intracavitary high-dose-rate brachytherapy in cervical cancer.
    J Contemp Brachytherapy. 2020;12:201-206.
    PubMed         Abstract available

  20. VLACHOVA Z, Dolezel M, Svozilova K, Jaskova P, et al
    Prolonged treatment planning can increase real rectal dose in 3D brachytherapy for cervical cancer.
    J Contemp Brachytherapy. 2020;12:118-123.
    PubMed         Abstract available

  21. GURSEL SB, Serarslan A, Meydan AD, Okumus N, et al
    A comparison of tandem ring and tandem ovoid treatment as a curative brachytherapy component for cervical cancer.
    J Contemp Brachytherapy. 2020;12:111-117.
    PubMed         Abstract available


    J Immunol Res

  22. YANG-CHUN F, Sen-Yu W, Yuan Z, Yan-Chun H, et al
    Genome-Wide Profiling of Human Papillomavirus DNA Integration into Human Genome and Its Influence on PD-L1 Expression in Chinese Uygur Cervical Cancer Women.
    J Immunol Res. 2020;2020:6284960.
    PubMed         Abstract available

  23. LI X, Zhou W, Liang Y, Xu C, et al
    The Immunotherapeutic Effect of SIRPalpha-Silenced DCs against Cervical Cancer.
    J Immunol Res. 2020;2020:1705187.
    PubMed         Abstract available


    J Infect

  24. LEFEUVRE C, Pivert A, Guillou-Guillemette HL, Fabiani FL, et al
    Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France.
    J Infect. 2020 May 12. pii: S0163-4453(20)30276.
    PubMed         Abstract available


    LGBT Health

  25. MAZA M, Melendez M, Herrera A, Hernandez X, et al
    Cervical Cancer Screening with Human Papillomavirus Self-Sampling Among Transgender Men in El Salvador.
    LGBT Health. 2020 May 14. doi: 10.1089/lgbt.2019.0202.
    PubMed         Abstract available


    Mater Sociomed

  26. HRGOVIC Z, Fures R, Jaska S
    Implementation of the Program for Early Detection of Cervical Cancer in the Federal Republic of Germany.
    Mater Sociomed. 2020;32:62-65.
    PubMed         Abstract available


    Med Ultrason

  27. DUDEA-SIMON M, Dudea SM, Burde A, Ciortea R, et al
    Usefulness of real time elastography strain ratio in the assessment of cervical intraepithelial neoplasia and cervical cancer using a reference material.
    Med Ultrason. 2020;22:145-151.
    PubMed         Abstract available


    Minerva Ginecol

  28. PIMPLE SA, Mishra GA, Deodhar KK
    Evidence based appropriate triage strategies for implementing high risk HPV as primary technology in cervical cancer screening.
    Minerva Ginecol. 2020;72:96-105.
    PubMed         Abstract available


    Mol Biol Rep

  29. MONTOYA-GOMEZ A, Montealegre-Sanchez L, Garcia-Perdomo HA, Jimenez-Charris E, et al
    Cervical cancer and potential pharmacological treatment with snake venoms.
    Mol Biol Rep. 2020 May 13. pii: 10.1007/s11033-020-05503.
    PubMed         Abstract available


    Mol Cell Biochem

  30. TIAN Y, Xu Z, Fu J
    CircularRNA-9119 promotes the proliferation of cervical cancer cells by sponging miR-126/MDM4.
    Mol Cell Biochem. 2020 May 8. pii: 10.1007/s11010-020-03745.
    PubMed         Abstract available


    Mol Oncol

  31. YANG S, Wu Y, Wang S, Xu P, et al
    HPV-related methylation-based reclassification and risk stratification of cervical cancer.
    Mol Oncol. 2020 May 14. doi: 10.1002/1878-0261.12709.
    PubMed         Abstract available


    Mol Ther Nucleic Acids

  32. LIN CL, Ying TH, Yang SF, Wang SW, et al
    Transcriptional Suppression of miR-7 by MTA2 Induces Sp1-Mediated KLK10 Expression and Metastasis of Cervical Cancer.
    Mol Ther Nucleic Acids. 2020;20:699-710.
    PubMed         Abstract available


    Oncol Lett

  33. KEERATICHAMROEN S, Subhasitanont P, Chokchaichamnankit D, Weeraphan C, et al
    Identification of potential cervical cancer serum biomarkers in Thai patients.
    Oncol Lett. 2020;19:3815-3826.
    PubMed         Abstract available


    Oncologist

  34. ISLA-ORTIZ D, Palomares-Castillo E, Mille Loera JE, Ramirez-Calderon N, et al
    Cervical Cancer in Young Women: Do They Have a Worse Prognosis? A Retrospective Cohort Analysis in a Population of Mexico.
    Oncologist. 2020 May 10. doi: 10.1634/theoncologist.2019-0902.
    PubMed         Abstract available


    Pathol Res Pract

  35. ZHANG J, Zhou M, Zhao X, Wang G, et al
    Long noncoding RNA LINC00173 is downregulated in cervical cancer and inhibits cell proliferation and invasion by modulating the miR-182-5p/FBXW7 axis.
    Pathol Res Pract. 2020 Apr 28:152994. doi: 10.1016/j.prp.2020.152994.
    PubMed         Abstract available


    PLoS One

  36. SERMAN F, Favre J, Deken V, Guittet L, et al
    The association between cervical cancer screening participation and the deprivation index of the location of the family doctor's office.
    PLoS One. 2020;15:e0232814.
    PubMed         Abstract available


    Prev Med

  37. HARDER E, Hertzum-Larsen R, Frederiksen K, Kjaer SK, et al
    Non-participation in cervical cancer screening according to health, lifestyle and sexual behavior: A population-based study of nearly 15,000 Danish women aged 23-45years.
    Prev Med. 2020 May 6:106119. doi: 10.1016/j.ypmed.2020.106119.
    PubMed         Abstract available


    Radiother Oncol

  38. OUD M, Kolkman-Deurloo IK, Mens JW, Lathouwers D, et al
    Fast and fully-automated multi-criterial treatment planning for adaptive HDR brachytherapy for locally advanced cervical cancer.
    Radiother Oncol. 2020;148:143-150.
    PubMed         Abstract available


    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

  39. LI Z, Luo Q, Wang H, Liu Y, et al
    [Knockdown of YTH N(6)-methyladenosine RNA binding protein 2 (YTHDF2) inhibits cell proliferation and promotes apoptosis in cervical cancer cells].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020;36:255-263.
    PubMed         Abstract available


    Zhong Nan Da Xue Xue Bao Yi Xue Ban

  40. ZOU T, Zheng C, Zhang Z, Yu L, et al
    Neoadjuvant chemotherapy efficacy and prognostic factors in 187 cervical cancer patients with IB2 and IIA2 stage.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45:297-304.
    PubMed         Abstract available


    Zhongguo Yi Xue Ke Xue Yuan Xue Bao

  41. LI M, Li O, Sun J, Zheng X, et al
    [Correlation between DNA Methylation of ZNF772 Promoter Region and Cervical Cancer].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2020;42:164-171.
    PubMed         Abstract available


    Zhonghua Yi Xue Za Zhi

  42. WANG P, Guo Z, Zhao DM, Xu HF, et al
    [Performance of high-risk HPV typing test in early diagnosis of cervical cancer].
    Zhonghua Yi Xue Za Zhi. 2020;100:1396-1400.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: